Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-49.51	13.41	26.56
Graham Fair Price	-2.47	5018.96	5146.20
PEG	-28.37	-0.05	0.07
Price/Book	-13.55	0.55	0.63
Price/Cash Flow	-254.78	-129.47	-36.49
Prices/Earnings	-8.12	9.73	-10.59
Price/Sales	-10.40	1.83	2.04
Price/FCF	-254.78	-129.47	-36.49
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	25.68	0.17	0.14
Operating Margin	2416.44	0.06	< 0.005
ROA	-5.75	< 0.005	-0.01
ROE	-0.01	0.01	-5.91
ROIC	< 0.005	0.01	508.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.13	-0.01	-921.22
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.97	23.41	2301.89
EPS QOQ	-1.52	1.95	28.28
FCF QOQ	-1.96	0.75	-61.51
Revenue QOQ	-0.17	-0.03	82.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	28.79	30.82	7.04
Days Sales Outstanding (DSO)	69.65	68.03	-2.32
Inventory Turnover	3.13	2.92	-6.57
Debt/Capitalization	0.20	0.18	-11.51
Quick Ratio	0.80	0.75	-5.84
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8873.17	8921.34	0.54
Cash	896.49	838.02	-6.52
Capex	-380.76	-601.34	-57.93
Free Cash Flow	-154.01	-37.73	75.50
Revenue	2752.40	2670.19	-2.99
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.07	1.03	-3.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.88	2.89	-50.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating